Breadcrumb

This Manual has been designed for use in the NICU at London Health Sciences Centre (LHSC), London, Ontario, Canada, and represents clinical practice at this institution. The information contained within the Manual may not be applicable to other centres. If users of this Manual are not familiar with a drug, it is recommended that the official monograph be consulted before it is prescribed and administered. Any user of this information is advised that the contributors, Editor and LHSC are not responsible for any errors or omissions, and / or any consequences arising from the use of the information in this Manual.

SODIUM POLYSTYRENE SULFONATE(Kayexalate(R))

We no longer use sodium polystyrene sulfonate (Kayexalate) since it can result in the formation of concretions.

Indication

treatment of hyperkalemia

Pharmacology

removes potassium from the body by exchanging sodium ions for potassium, particularly in the large intestine; potassium-containing resin is then excreted; small amounts of other cations such as calcium and magnesium may be lost during treatment: sodium retention may occur